Isocapnic Cold Air Challenge in Patients with COPD: Are There any Predisposing Factors?

REFERENCES

• Grootendorst D C, Rabe K F. Mechanisms of bronchial hyperreactivity in asthma and COPD. Proc Am Thorac Soc 2004; 1: 77–87
   PubMedGoogle Scholar
• Wise R A. The relationship between airways hyperreactivity and COPD. Eur Respir Rev 2002; 12: 386–389
   Google Scholar
• Joos G F, O'Connor B, Anderson S D, Chung F, Cockcroft D W, Dahlen B, Di Maria G, Foresi A, Hargreave F E, Holgate S T, Inman M, Lotvall J, Magnussen H, Polosa R, Postma D S, Riedler J. ERS Task Force Indirect airway challenges. Eur Respir J 2003; 21: 1050–1068
   PubMed Web of Science ®Google Scholar
• Ramsdale E H, Roberts R S, Morris M M, Hargreave F E. Differences in repsonsiveness to hyperventilation and methacholine in asthma and chronic bronchitis. Thorax, 40: 422–426
   PubMed Web of Science ®Google Scholar
• Ramsdale E H, Morris M M, Roberts R S, Hargreave F E. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984; 39: 912–918
   PubMed Web of Science ®Google Scholar
• Costello R W, Jacoby D B, Fryer A D. Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax 1998; 53: 613–618
   PubMed Web of Science ®Google Scholar
• Panning C A, De Bisschop M. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 2003; 23: 183–189
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. July, 2005, www.goldcopd.com Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute, April 2001; Update of the Management Sections, GOLD website Date updated
   Google Scholar
• American Thoracic Society. Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med 1998; 161: 309–329
   Web of Science ®Google Scholar
• Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127: 1553–1559
   PubMed Web of Science ®Google Scholar
• Modl M, Eber E, Steinbrugger B, Weinhanl E, Zach M S. Comparing methods for assessing bronchial responsiveness in children: single step cold air challenge, multiple step cold air challenge, and histamine provocation. Eur Respir J 1995; 8: 1742–1747
   PubMed Web of Science ®Google Scholar
• Zervas E, Loukides S, Papatheodorou G, Psathakis K, Tsindiris K, Panagou P, Kalogeropoulos N. Magnesium levels in plasma and in erythrocytes before and after histamine challenge. Eur Respir J 2000; 16: 621–625
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107–1136
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Pizzichini M M, Leigh R, Djukanovic R, Sterk P J. Safety of sputum induction. Eur Respir J 2002, Suppl 37: 9–18s
   Google Scholar
• Vincken W, van Noord J A, Greefhorst A P, Bantje T A, Kesten S, Korducki L, Cornelissen P J, Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002; 19(2)209, 216
   PubMed Web of Science ®Google Scholar
• Calverley P M, Burge P S, Spencer S, Anderson J A, Jones P W. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659–664
   PubMed Web of Science ®Google Scholar
• Anthonisen N R, Lindgren P G, Taskhin D P, Kanner R E, Scanlon P D, Connet J E, Lung Health Study Research Group. Bronchodilator response in Lung Health Study over 11 years. Eur Respir J 2005; 26: 45–51
   PubMed Web of Science ®Google Scholar
• Wise R A, Kanner R E, Lindgren P, Connet J E, Altose M D, Enright P L, Taskhin D P. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD. Chest 2003; 124: 449–458
   PubMed Web of Science ®Google Scholar
• Rutgers S R, Kerstjens H A, Timens W, Tzanakis N, Kauffman H F, Postma D S. Airway inflammation and hyperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease. Clin Exp Allergy 2000; 30: 657–662
   PubMed Web of Science ®Google Scholar
• He J Q, Connett J E, Anthonisen N R, Sanford A J. Polymorphisms in the IL-13, IL-13RA1 and IL-4RA genes and rate of decline in lung function in smokers. Am J Respir Cell Mol Biol 2003; 28: 379–385
   PubMed Web of Science ®Google Scholar
• Martin J G, Duguet A, Eidelman D H. The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. Eur Respir J 2000; 16: 349–354
   PubMed Web of Science ®Google Scholar
• Wiggs B R, Busken C, Paré P, James A, Hogg J C. A model of airway narrowing in asthma and in chronic obstructive airways disease. Am Rev Respir Dis 1992; 145: 1251–1258
   PubMed Web of Science ®Google Scholar
• Gosens R, Zaagsma J, Meurs H, Halayko A J. Muscarinic receptor signalling in the pathophysiology of asthma and COPD. Respir Res 2006; 7: 73
   PubMed Web of Science ®Google Scholar
• Fryer A D, Jacoby D B. Muscarinic receptors and control of airway smooth muscle. Am J Respir Cri Care Med 1998; 158: S154–S160
   PubMed Web of Science ®Google Scholar
• On L S, Boonyongsunchai P, Webb S, Davies L, Calverley P M, Costello R W. Function of pulmonary neuronal M2 muscarinic receptors in stable Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 163: 1320–1325
   PubMed Web of Science ®Google Scholar
• Struckmann N, Schwering S, Wiegand S, Gschnell A, Yamada M, Kummer W, Wess J, Haberberger R V. Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol Pharmacol 2003; 64: 1444–1451
   PubMed Web of Science ®Google Scholar
• Kadota H, Kuwahara M, Nishibata R, Mikami H, Tsubone H. Effect of M2 and M3 muscarinic receptors on airway responsiveness to carbachol in bronchial-hypersensitive (BHS) and bronchial-hyposensitive (BHR) guinea pigs. Exp Anim 2001; 50: 49–58
   PubMed Web of Science ®Google Scholar
• Patel H J, Douglas G J, Herd C M, Spina D, Giembycz M A, Barnes P J, Belvisi M G, Page C P. Antigen-induced bronchial hyperresponsiveness in the rabbit is not dependent on M(2)-receptor dysfunction. Pulm Pharmacol Ther 1999; 12: 245–255
   PubMed Web of Science ®Google Scholar
• Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 2003; 123(5)1441–1449
   PubMed Web of Science ®Google Scholar